On Demand Learning

21 Results

  • The Current Evidence On Telemedicine-Delivered Treatment for Opioid and Other Substance Use Disorders

    Contains 3 Component(s)

    This is the fifth webinar in the telehealth series for the Opioid Response Network (ORN). Funding for this initiative was made possible (in part) by grant no. 6H79TI080816 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or oganizations imply endorsement by the U.S. Government.

  • Q&A - Telemedicine for OUD in the Indian Health Service

    Contains 3 Component(s) Recorded On: 08/26/2020

    This webinar is part of the telehealth series for the Opioid Response Network (ORN). Funding for this initiative was made possible (in part) by grant no. 6H79TI080816 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or oganizations imply endorsement by the U.S. Government.

  • Telemedicine for OUD in the Indian Health Service

    Contains 3 Component(s)

    This is the fourth webinar in the telehealth series for the Opioid Response Network (ORN). Funding for this initiative was made possible (in part) by grant no. 6H79TI080816 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or oganizations imply endorsement by the U.S. Government.

  • Q&A Session - Telehealth for Opioid Use Disorder during the COVID-19 Pandemic and Beyond

    Contains 3 Component(s)

    This is the Q&A session for the third webinar in the telehealth series for the Opioid Response Network (ORN). There have been significant telehealth legal, regulatory, and reimbursement changes at the federal and state level in the context of the COVID-19 pandemic. These changes have allowed for a rapid expansion of telehealth nationally, including for the assessment and treatment of mental health and substance use disorders. This webinar, hosted by the American Osteopathic Academy of Addiction Medicine through a Opioid Response Network STR-TA grant, will cover the telehealth legal, regulatory, clinical, and reimbursement landscape prior to and during the pandemic. The webinar will focus on telehealth for the treatment of opioid use disorder and will include an overview of key laws and regulations including the Ryan Haight Act, the Substance Use–Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, and relevant changes made during the national public health emergency (PHE). The webinar will include a discussion of what the future telehealth landscape may look like once the national PHE and state-by-state executive orders and emergency declarations are lifted. Funding for this initiative was made possible (in part) by grant no. 6H79TI080816 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

  • Telehealth for Opioid Use Disorder during the COVID-19 Pandemic and Beyond

    Contains 3 Component(s)

    This is the third webinar in the telehealth series for the Opioid Response Network (ORN). There have been significant telehealth legal, regulatory, and reimbursement changes at the federal and state level in the context of the COVID-19 pandemic. These changes have allowed for a rapid expansion of telehealth nationally, including for the assessment and treatment of mental health and substance use disorders. This webinar, hosted by the American Osteopathic Academy of Addiction Medicine through a Opioid Response Network STR-TA grant, will cover the telehealth legal, regulatory, clinical, and reimbursement landscape prior to and during the pandemic. The webinar will focus on telehealth for the treatment of opioid use disorder and will include an overview of key laws and regulations including the Ryan Haight Act, the Substance Use–Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, and relevant changes made during the national public health emergency (PHE). The webinar will include a discussion of what the future telehealth landscape may look like once the national PHE and state-by-state executive orders and emergency declarations are lifted. Funding for this initiative was made possible (in part) by grant no. 6H79TI080816 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

  • Essentials: Prescribing Naloxone to Patients for Overdose Reversal

    Contains 4 Component(s), Includes Credits

    This lecture is designed to provide the learner with brief history of the events in the late 1990s that resulted in today's opioid epidemic, discuss the epidemiology of opioid overdose and the neurobiology of overdose. Risk factors for overdose, the use of naloxone for overdose, and state laws regarding prescribing naloxone will be discussed.